IP LAW PLATFORM
propriété intellectuelle
intellectual property
contributeurs
contributors
concours
contest
bulletins
reviews
s'inscrire
join us
Chercher/Search
connexion
log in 
 déconnexion
log out
à propos
about
conditions
terms of use
plan
sitemap
contact
contact
admin
admin





retour / back


USA: Reverse Merger Merck-Schering Plough - IP Lawyers in the Driving Seat




By Sébastien ODDOS member of a.d.c.i. - Date : 2010-03-12 - Country : ETATS-UNIS - Subject : Economics - IP Field : Intellectual Property


For once it is not corporate lawyers but IP lawyers who are very much in the driving seat!

We understand that the $41.1 billion Merck-Schering Plough merger announced yesterday will be structured as a reverse merger. Interestingly, the corporate structure of the transaction seems to be intellectual property driven. Schering-Plough markets the ($2.1 billion in annual sales) Remicade outside of the US under a license agreement with Johnson and Johnson which sells the drug in America. This agreement contains a termination clause that stipulates that the ex-US rights to Remicade (and another drug being developed) would revert to Johnson and Johnson if control or ownership of Schering [...]

En savoir plus ? Pour cela, créer GRATUITEMENT votre compte. Dans une seconde, vous pourrez poursuivre votre lecture.
Learn more? If so, create your FREE account. It will take you a second before going back to this paper.



OUVRIR MON COMPTE
CREATE MY ACCOUNT